| 名稱 | mMRGPRB2/Ga15/HEK293 |
| 型號 | CBP71341 |
| 報價 |  |
| 特點 | mMRGPRB2/Ga15/HEK293 凍存條件：90% FBS+10% DMSO |
產(chǎn)品搜索
相關(guān)文章
- MicroRNA或可特異性地殺死攜帶常見突變的癌細(xì)胞
- 【產(chǎn)品推介】T細(xì)胞活化篩選模型
- 科學(xué)家有望利用對療法敏感性的癌細(xì)胞來清除耐藥性癌細(xì)胞
- HPV分子診斷標(biāo)準(zhǔn)品擴容：精準(zhǔn)檢測，實力升級
- JCI:華人科學(xué)家發(fā)現(xiàn)促進(jìn)乳腺癌進(jìn)展轉(zhuǎn)移的表觀修飾閱讀者
- 心衰治療靶點：BNP/NPR1
- 關(guān)于sigma試劑的使用時長相關(guān)說明
- DPCR檢測試劑盒開發(fā)性能驗證
- NKG2A細(xì)胞篩選模型
- 腫瘤細(xì)胞上的DNA排列方式探討
聯(lián)系我們
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > GPCR細(xì)胞株 > CBP71341mMRGPRB2/Ga15/HEK293
- 詳細(xì)內(nèi)容
| CBP71341 | |
| I. Background | |
Mast cell-specific receptor for basic secretagogues, i.e. cationic amphiphilic drugs, as well as endo- or exogenous peptides, consisting of a basic head group and a hydrophobic core. Recognizes and binds small molecules containing a cyclized tetrahydroisoquinoline (THIQ), such as non-steroidal neuromuscular blocking drugs (NMBDs), including tubocurarine and atracurium. In response to these compounds, mediates pseudo-allergic reactions characterized by histamine release, inflammation and airway contraction. | |
| II. Introduction | |
| Host Cell: | HEK293 |
| Stability: | 20 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
| Freeze Medium: | 90% FBS+10% DMSO |
| Culture Medium: | DMEM+10%FBS+400ug/ml G418+ 100 μg/ml Hygromycin B |
| Mycoplasma Status: | Negative |
| Storage: | Liquid nitrogen immediately upon delivery |
| Application(s): | Functional assay for mMRGPRB2 receptor |
| Transducer: | Gi |
| Ⅲ. Description of Host Cell Line | |
| Organism: | Human |
| Tissue: | kidney |
| Morphology: | Epithelial |
| Growth Properties: | Adherent |
| Ⅳ. Representative Data | |
Figure 1. mMRGPRB2/Ga15/HEK293, the EC50 was 1.47μg/ml. | |
